ARG70215
SARS-CoV nucleocapsid recombinant protein (His-SUMO tagged, N-ter)
SARS-CoV nucleocapsid recombinant protein (His-SUMO tagged, N-ter) for SDS-PAGE and Virus
Publication1
Overview
| Product Description | HEK293 expressed, His-SUMO tagged (N-ter) SARS-CoV nucleocapsid recombinant protein. |
|---|---|
| Tested Reactivity | Virus |
| Tested Application | SDS-PAGE |
| Target Name | SARS-CoV nucleocapsid protein |
| Species | Virus |
| A.A. Sequence | MSDNG PQSNQ RSAPR ITFGG PTDST DNNQN GGRNG ARPKQ RRPQG LPNNT ASWFT ALTQH GKEEL RFPRG QGVPI NTNSG PDDQI GYYRR ATRRV RGGDG KMKEL SPRWY FYYLG TGPEA SLPYG ANKEG IVWVA TEGAL NTPKD HIGTR NPNNN AATVL QLPQG TTLPK GFYAE GSRGG SQASS RSSSR SRGNS RNSTP GSSRG NSPAR MASGG GETAL ALLLL DRLNQ LESKV SGKGQ QQQGQ TVTKK SAAEA SKKPR QKRTA TKQYN VTQAF GRRGP EQTQG NFGDQ DLIRQ GTDYK HWPQI AQFAP SASAF FGMSR IGMEV TPSGT WLTYH GAIKL DDKDP QFKDN VILLN KHIDA YKTFP PTEPK KDKKK KTDEA QPLPQ RQKKQ PTVTL LPAAD MDDFS RQLQN SMSGA SADST QA with polyhistidine-SUMO tag at the N-terminus. |
| Expression System | HEK293 |
Properties
| Form | Powder |
|---|---|
| Purification | Ni-NTA chromatography. |
| Purification Note | Endotoxin level is less than 0.1 EU/µg of the protein, as determined by the LAL test. |
| Purity | > 98% (by SDS-PAGE) |
| Buffer | PBS (pH 7.4) |
| Reconstitution | It is recommended to reconstitute the lyophilized protein in sterile water to a concentration not less than 100 µg/ml and incubate the stock solution for at least 20 min at room temperature to make sure the protein is dissolved completely. |
| Storage Instruction | Lyophilized protein should be stored at -20°C. After reconstitution, aliquot and store at -20°C or -80°C for up to one month. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. |
| Note | For laboratory research only, not for drug, diagnostic or other use. |
Bioinformation
| Highlight | Related products: SARS-CoV antibodies; SARS-CoV ELISA Kits; SARS-CoV recombinant proteins; Related news: HMGB1, a biomarker and therapeutic target in COVID-19 Exploring Antiviral Immune Response |
|---|
Specific References
Microfluidic Magneto Immunosensor for Rapid, High Sensitivity Measurements of SARS-CoV-2 Nucleocapsid Protein in Serum.
Others / Virus
